Today: 16 May 2026
Browse Category

NASDAQ:VFS 28 March 2026

VinFast Stock Price Jumps 5% as VFS Rally Builds Despite Loss Concerns (Reuters)

VinFast Stock Price Jumps 5% as VFS Rally Builds Despite Loss Concerns (Reuters)

VinFast Auto (VFS) shares rose over 5% Friday to $3.39, capping an 18.5% gain for the week after reporting 2025 preliminary results showing EV deliveries doubled to 196,919 and revenue up 105.4%. The company’s Q4 net loss widened to about $1.4 billion, with gross margin at negative 39.9%. About 33% of Q4 deliveries went to affiliated entities. VinFast expects to file its audited annual report by April 30.

Stock Market Today

  • Canada’s Infrastructure Boom Boosts TSX Stocks Calian Group, Bird Construction, WSP Global
    May 15, 2026, 8:47 PM EDT. Canada's infrastructure investment surge is poised to benefit key TSX stocks. Calian Group (TSX:CGY) gained 49% in 2026 with an 18% revenue rise and a $1.5 billion backlog, driven by defence contracts. Bird Construction (TSX:BDT), up 78% this year, holds a $5.4 billion backlog, specializing in industrial projects with improving profit margins. WSP Global (TSX:WSP), a $25 billion capped engineering firm, also stands to profit. These stocks reflect Canada's focus on economic growth through enhanced infrastructure and deregulation supporting national projects.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop